Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dramatic response to trastuzumab and paclitaxel in a patient with human epidermal growth factor receptor 2-positive metastatic cholangiocarcinoma.

Literature DB >> 22851567

Dramatic response to trastuzumab and paclitaxel in a patient with human epidermal growth factor receptor 2-positive metastatic cholangiocarcinoma.

Lisa Y Law¹.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 22851567 DOI： 10.1200/JCO.2012.42.3061

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

29 in total

Review 1. Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies.

Authors: Trang H Au; Kai Wang; David Stenehjem; Ignacio Garrido-Laguna
Journal: J Gastrointest Oncol Date: 2017-06

Review 2. Progression of targeted therapy in advanced cholangiocarcinoma.

Authors: Yingying Huang; Xiaomei Li; Yunbo Zhao
Journal: Chin J Cancer Res Date: 2015-04 Impact factor: 5.087

3. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.

Authors: Apinya Jusakul; Ioana Cutcutache; Chern Han Yong; Jing Quan Lim; Mi Ni Huang; Nisha Padmanabhan; Vishwa Nellore; Sarinya Kongpetch; Alvin Wei Tian Ng; Ley Moy Ng; Su Pin Choo; Swe Swe Myint; Raynoo Thanan; Sanjanaa Nagarajan; Weng Khong Lim; Cedric Chuan Young Ng; Arnoud Boot; Mo Liu; Choon Kiat Ong; Vikneswari Rajasegaran; Stefanus Lie; Alvin Soon Tiong Lim; Tse Hui Lim; Jing Tan; Jia Liang Loh; John R McPherson; Narong Khuntikeo; Vajaraphongsa Bhudhisawasdi; Puangrat Yongvanit; Sopit Wongkham; Yasushi Totoki; Hiromi Nakamura; Yasuhito Arai; Satoshi Yamasaki; Pierce Kah-Hoe Chow; Alexander Yaw Fui Chung; London Lucien Peng Jin Ooi; Kiat Hon Lim; Simona Dima; Dan G Duda; Irinel Popescu; Philippe Broet; Sen-Yung Hsieh; Ming-Chin Yu; Aldo Scarpa; Jiaming Lai; Di-Xian Luo; André Lopes Carvalho; André Luiz Vettore; Hyungjin Rhee; Young Nyun Park; Ludmil B Alexandrov; Raluca Gordân; Steven G Rozen; Tatsuhiro Shibata; Chawalit Pairojkul; Bin Tean Teh; Patrick Tan
Journal: Cancer Discov Date: 2017-06-30 Impact factor: 39.397

Review 4. Banxia Xiexin Decoction () Combined with Afatinib in Treatment of Advanced Gallbladder Cancer: Case Report and Literature Review.

Authors: Li Su; Miao-Miao Wang; Meng-Ran Xu; Xiao Wang; Hong-Zhen Xia; Mei Zhang; Lei Zheng; Yao-Dong Zhu; Ming-Qi Wang; Ping Li
Journal: Chin J Integr Med Date: 2019-02-01 Impact factor: 1.978

Dramatic response to trastuzumab and paclitaxel in a patient with human epidermal growth factor receptor 2-positive metastatic cholangiocarcinoma.

Review 1. Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies.

Review 2. Progression of targeted therapy in advanced cholangiocarcinoma.

3. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.

Review 4. Banxia Xiexin Decoction () Combined with Afatinib in Treatment of Advanced Gallbladder Cancer: Case Report and Literature Review.

5. A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status.

6. Targeted agents: how can we improve the outcome in biliary tract cancer?

Review 7. Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy.

8. The dream and reality of histology agnostic cancer clinical trials.

Review 9. Precision medicine in cholangiocarcinoma.

Review 10. Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisation.